The CLL Society’s Bruce Wright Appointed to Represent the Veteran’s Community for SWOG SWOG, formerly known as the Southwest Oncology Group, is a well-respected National Cancer Institute (NCI) supported organization that conducts and... September 11, 2020CLL Society News, NewsBy Brad Hedrick
When CLL Meets COVID-19 The journal BLOOD has just published this excellent commentary on the two large studies on SARS-Cov2 infections in CLL patients. For... September 10, 2020C19 - Updates, NewsBy Brad Hedrick
New approval for venetoclax for Acute Myeloid Leukemia (AML) The U.S. Food and Drug Administration (FDA) has granted full approval of venetoclax in combination with azacitidine, or decitabine, or... August 20, 2020Business, Finances, Insurance & RegulatoryBy Brad Hedrick
Patient Education Webcast—Expert Perspectives on Incorporating BTK Inhibitors into the Treatment Plan for Patients with CLL: Helpful Information for Patients and their Caregivers. Expert Perspectives on Incorporating BTK Inhibitors into the Treatment Plan for Patients with CLL: Helpful Information for Patients and their... August 20, 2020NewsBy Brad Hedrick
What You Need to Know about BTK Inhibitors as Treatment for Your/Your Loved One’s CLL What You Need to Know about BTK Inhibitors as Treatment for Your/Your Loved One’s CLL Recorded August 10, 2020 In this archived virtual... August 20, 2020NewsBy Brad Hedrick
CLL Society’s Official Statement Concerning CLL (chronic lymphocytic leukemia) Patients Working and Traveling During the COVID-19 Pandemic (8/16/2020 update) CLL Society’s Official Statement Concerning CLL (chronic lymphocytic leukemia) Patients Working and Traveling During the COVID-19 Pandemic (8/16/2020 update) As the... August 20, 2020CLL Society News, COVID-19, News, Official Statements and Press ReleasesBy Brad Hedrick
CURE Educated Patient CLL Webinar – August 27, 2020 CURE Educated Patient CLL Webinar Thursday, August 27, 2020CURE® is proud to bring additional expert insight to Chronic Lymphocytic Leukemia patients... August 17, 2020NewsBy Brad Hedrick
FDA Clearance for clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia (CLL) This is good news for CLL patients as measurement for MRD (minimal or measurable residual disease) is increasingly being recognized... August 11, 2020Business, Finances, Insurance & Regulatory, MRD & Disease MonitoringBy Brad Hedrick
COVID-19 severity and mortality in chronic lymphocytic leukemia (CLL) patients With recent publications in two well respected and influential peer reviewed journals, BLOOD and LEUKEMIA (NATURE GROUP), we are finally... July 27, 2020C19 - Updates, COVID-19 Managing Re-Entry, NewsBy Brad Hedrick
Gilead Gets Another CAR-T Approval, This Time for Mantle Cell Lymphoma Hopefully the next approval will be for CLL patients, but there is still much work to be done in clinical... July 27, 2020Business, Finances, Insurance & Regulatory, CAR-TBy Brad Hedrick
